# Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis

> **NCT02462083** · PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 555 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** IDP-118 Lotion

## Key facts

- **NCT ID:** NCT02462083
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-11
- **Primary completion:** 2017-01-31
- **Final completion:** 2017-04-24
- **Target enrollment:** 555 (ACTUAL)
- **Last updated:** 2020-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02462083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02462083, "Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02462083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*